Benefit Expectations and Neuroprotective Prescribing for Acute Ischemic Stroke in China

Background: Neuroprotective therapies are frequently used for acute ischemic stroke in China. We examined associations of neurologists? self-rated familiarity, perceived importance, and benefit expectations with reported prescribing frequency. Methods: A hospital-based quota survey recruited attending-level or senior neurologists involved in acute ischemic stroke care across mainland China from May 27 to July 16, 2025. High-frequency use was defined as prescribing neuroprotective therapy to at least 60% of patients. High familiarity and importance were ratings of 4 or 5 on 5-level scales; cons

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.